Clinical Trials Browser

Phase 4 × pasireotide × Gastrointestinal × Clear all

NCT02779257 2022-03-04

Pasireotide Treatment for Neuroendocrine Tumor

Phase 4 Withdrawn

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Hypoglycemia

NCT02775227 2020-08-24

HYPAR

Phase 4 Active not recruiting

Gastrointestinal

Pancreatic Fistula, Pancreatic Neoplasms